eClinicalHealth Introduces Clinpal EDC Patient-Centric Cloud Platform
Stirling, UK, 13 July 2017-eClinicalHealth introduced Clinpal EDC, an application for data capture on a single cloud platform that enables an intuitive experience for patients and sites as well as all sponsor and CRO stakeholders.
With over five years of development and use in numerous live trials, Clinpal EDC is created for Phase II through Phase IV post-marketing studies, observational studies, and registries, with no upper limit on the number of sites or patients.
“Clinpal EDC offers a modern and advanced cloud approach to electronic data capture that provides natural workflows to sites, sponsors, and CROs, while involving patients in the trial lifecycle,” said Doug Bain, Chief Technology Officer at eClinicalHealth.
Clinpal EDC is a single cloud platform to recruit patients through targeted websites and social networks, qualify and enroll them, and then collect data for retention and protocol compliance throughout the clinical trial process.
“Our EDC platform is unique in that it has shortened delivery times, reduced costs, and enabled sponsors to collect source data directly from thousands of patients while meeting global regulatory requirements,” said Ian Mills, Lead Architect of Clinpal EDC.
The Clinpal EDC package has a patient-centric focus to EDC, is built on a cloud platform, and is suited for commercial, academic, and hospital-based research teams.
To find out more about Clinpal EDC, click here.
About eClinicalHealth
For over 5 years, Clinpal EDC has been capturing data from patients in studies across 41 countries on 6 continents in virtually all local languages. These projects have integrated a variety of biometric data and range from small proof-of-concept trials to large global patient registries.
Contact: Suzie Harvey
Email: info@eClinicalHealth.com
Office: +44 333 012 4205
Web: www.clinpal.com
Join our community: LinkedIn | Twitter
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.
